Neimeth International Pharmaceuticals Plc (NGX: NEIMETH)
Nigeria
· Delayed Price · Currency is NGN 2.040
+0.110 (5.70%)
At close: Sep 13, 2024
NEIMETH Income Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2015 |
| Revenue | 2,909 | 2,210 | 2,919 | 2,703 | 3,047 | 2,839 | Upgrade
|
| Revenue Growth (YoY) | 29.74% | -24.31% | 8.01% | -11.28% | 7.31% | 19.73% | Upgrade
|
| Cost of Revenue | 1,567 | 1,500 | 1,886 | 1,629 | 1,622 | 1,348 | Upgrade
|
| Gross Profit | 1,342 | 709.15 | 1,033 | 1,074 | 1,425 | 1,491 | Upgrade
|
| Selling, General & Admin | 1,416 | 1,636 | 1,204 | 1,125 | 1,074 | 938.84 | Upgrade
|
| Other Operating Expenses | -147.7 | -157.38 | -157.95 | -26.15 | -197.17 | -145.91 | Upgrade
|
| Operating Expenses | 1,268 | 1,478 | 1,046 | 1,099 | 876.42 | 792.93 | Upgrade
|
| Operating Income | 73.11 | -769.05 | -12.39 | -24.8 | 548.74 | 697.94 | Upgrade
|
| Interest Expense | -838.1 | -667.95 | -300 | -181.77 | -188.22 | -212.76 | Upgrade
|
| Interest & Investment Income | 130.82 | 129.23 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -1,473 | -1,451 | 1.94 | 96.89 | -0.09 | -188.05 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -2,108 | -2,758 | -310.45 | -109.67 | 360.43 | 297.13 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.97 | 0.97 | - | - | 4.86 | - | Upgrade
|
| Pretax Income | -2,107 | -2,757 | -310.44 | -109.66 | 365.28 | 297.39 | Upgrade
|
| Income Tax Expense | 107.88 | 107.88 | 14.6 | - | 94.71 | 84.91 | Upgrade
|
| Net Income | -2,215 | -2,865 | -325.04 | -109.66 | 270.58 | 212.48 | Upgrade
|
| Net Income to Common | -2,215 | -2,865 | -325.04 | -109.66 | 270.58 | 212.48 | Upgrade
|
| Net Income Growth | - | - | - | - | 27.34% | -3.48% | Upgrade
|
| Shares Outstanding (Basic) | 4,273 | 4,273 | 1,899 | 1,899 | 1,899 | 1,899 | Upgrade
|
| Shares Outstanding (Diluted) | 4,273 | 4,273 | 1,899 | 1,899 | 1,899 | 1,899 | Upgrade
|
| Shares Change (YoY) | 38.46% | 125.00% | - | - | - | - | Upgrade
|
| EPS (Basic) | -0.52 | -0.67 | -0.17 | -0.06 | 0.14 | 0.11 | Upgrade
|
| EPS (Diluted) | -0.52 | -0.67 | -0.17 | -0.06 | 0.14 | 0.11 | Upgrade
|
| EPS Growth | - | - | - | - | 27.34% | -3.48% | Upgrade
|
| Free Cash Flow | -1,239 | -1,710 | -1,137 | -1,205 | 1.96 | -261.53 | Upgrade
|
| Free Cash Flow Per Share | -0.29 | -0.40 | -0.60 | -0.63 | 0.00 | -0.14 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.070 | 0.065 | Upgrade
|
| Dividend Growth | - | - | - | - | 7.69% | - | Upgrade
|
| Gross Margin | 46.12% | 32.09% | 35.39% | 39.74% | 46.78% | 52.51% | Upgrade
|
| Operating Margin | 2.51% | -34.81% | -0.42% | -0.92% | 18.01% | 24.58% | Upgrade
|
| Profit Margin | -76.13% | -129.68% | -11.13% | -4.06% | 8.88% | 7.48% | Upgrade
|
| Free Cash Flow Margin | -42.58% | -77.37% | -38.95% | -44.57% | 0.06% | -9.21% | Upgrade
|
| EBITDA | 215.51 | -642.96 | 96.02 | 94.78 | 639.06 | 808.66 | Upgrade
|
| EBITDA Margin | 7.41% | -29.10% | 3.29% | 3.51% | 20.98% | 28.48% | Upgrade
|
| D&A For EBITDA | 142.4 | 126.09 | 108.41 | 119.57 | 90.32 | 110.72 | Upgrade
|
| EBIT | 73.11 | -769.05 | -12.39 | -24.8 | 548.74 | 697.94 | Upgrade
|
| EBIT Margin | 2.51% | -34.81% | -0.42% | -0.92% | 18.01% | 24.58% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 25.93% | 28.55% | Upgrade
|
| Advertising Expenses | - | 363.67 | - | 188.49 | 224.46 | 156.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.